Brains

Het Supplement Brains van Fundamentals is het ultieme omega 3 product en bevat 100% Superba Krill olie met astaxanthin. Deze superieure bron van omega 3 vetzuren is krachtiger dan normale vis- en algenolie.

Aanbevolen gebruik:
Dagelijks 2 softgels. Bij voorkeur tijdens de maaltijd.

Voedingssupplement: 
Categorie vetzuren

Bewaren:
Koel en droog bewaren. Buiten het bereik van jonge kinderen houden.

Allergie informatie:
Dit product bevat garnaaltjes (krill).

Ingrediënten:
Superba Krill Olie, rundergelatine, sorbitol, glycerol, water, vanilla.

Samenstelling per dosering:
Superba Krill Olie 1000 mg Krill

Totaal omega-3 vetzuren   – 250 mg
Waarvan: – EPA – 120 mg & DHA – 70 mg
Phospholipiden   – 450 mg
Astaxanthin – 1100 mcg
Totaal omega 6   – 22 mg

 

References:

  • Djousse L, Arnett DK, Carr JJ, et al. Dietary linolenic acid is inversely associated with calcified atheros- clerotic plaque in the coronary arteries: the National Heart, Lung, and Blood Institute Family Heart Study. Circulation 2005;111:2921-6.
  • Djousse L, Arnett DK, Pankow JS, et al. Dietary linolenic acid is associated with a lower prevalence of hypertension in the NHLBI Family Heart Study. Hypertension 2005;45:368-73.
  • Brouwer IA, Katan MB, Zock PL. Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis. J Nutr 2004;134:919-22.
  • Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 2002;159:477-9.
  • Lucas M, Asselin G, Merette C, et al. Effects of ethyl-eicosapentaenoic acid omega-3 fatty acid sup- plementation on hot flashes and quality of life among middle-aged women: a double-blind, placebo- controlled, randomized clinical trial. Menopause 2009;16:357-66.
  • Mayser P, Mrowietz U, Arenberger P, et al. Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trial. J Am Acad Dermatol 1998;38:539-47.
  • Foster RH, Hardy G, Alany RG Borage oil in the treatment of atopic dermatitis. Nutrition. 2010 Jul- Aug;26(7-8):708-18.
  • Song C; Zhao S, Omega-3 fatty acid eicosapentaenoic acid. A new treatment for psychiatric and neurode- generative diseases: a review of clinical investigations. Expert Opin Investig Drugs – 01-OCT-2007; 16(10): 1627-38.
  • Surette ME; Stull D; Lindemann J, The impact of a medical food containing gammalinolenic and eicos- apentaenoic acids on asthma management and the quality of life of adult asthma patients. Curr Med Res Opin – 01-FEB-2008; 24(2): 559-67
  • Chapkin RS; Kim W; Lupton JR; McMurray DN. Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids – 01-AUG-2009; 81(2-3): 187-91
  • Fetterman JW Jr; Zdanowicz MM, Therapeutic potential of n-3 polyunsaturated fatty acids in disease. Am J Health Syst Pharm – 1-JUL-2009; 66(13): 1169-79
  • Saugstad LF Are neurodegenerative disorder and psychotic manifestations avoidable brain dysfunctions with adequate dietary omega-3? Nutr Health – 01-JAN-2006; 18(2): 89-101
  • Gillette-Guyonnet S; Andrieu S; Dantoine T; Dartigues JF; Touchon J; Vellas B, Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer’s disease. Alzheimer Dement – 01-MAR-2009; 5(2): 114-21.
  • Cannon D,From fish oil to microalgae oil … A win-win shift for humans and our habitat. Explore (NY) – 01- SEP-2009; 5(5): 299-303.
  • Tassoni D; Kaur G; Weisinger RS; Sinclair AJ, The role of eicosanoids in the brain. Asia Pac J Clin Nutr – 01-JAN-2008; 17 Suppl 1: 220-8.Crawford MA, Docosahexaenoic acid in neural signaling systems. Nutr Health – 01-JAN-2006; 18(3): 263-76
  • Lagarde M; Bernoud N; Thiès F; Brossard N; Lemaitre-Delaunay D; Croset M; Lecerf J Lysophosphatidyl- choline as a carrier of docosahexaenoic acid to target tissues. World Rev Nutr Diet – 01-JAN-2001; 88:173-7.
  • Kalmijn S., Fatty acid intake and the risk of dementia and cognitive decline: a review of clinical and epidemiological studies.- J Nutr Health Aging – 01-JAN-2000; 4(4): 202-7.
  • Tou JC; Jaczynski J; Chen YC., Krill for human consumption: nutritional value and potential health benefits. Nutr Rev – 01-FEB-2007; 65(2): 63-77.
  • Valentine RC, Valentine DL. Omega-3 fatty acids in cellular membranes: a unified concept Prog Lipid Res. 2004 Sep;43(5):383-402.
  • Kidd PM. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern Med Rev. 2007 Sep;12(3):207-27.
  • Calder PC. The relationship between the fatty acid composition of immune cells and their function. Prostaglandins Leukot Essent Fatty Acids. 2008 Sep-Nov;79(3-5):101-8. Epub 2008 Oct 23
  • Litman, B. J., et al . The role of docosahexaenoic acid containing phospholipids in modulating G protein-coupled signaling pathways : visual transduction. J. Mol. Neurosci. 16(2-3):237-242, 2001.
  • Yashodhara BM; Umakanth S; Pappachan JM; Bhat SK; Kamath R; Choo BH. Omega-3 fatty acids: a comprehensive review of their role in health and disease. Postgrad Med J – 01-FEB-2009; 85(1000): 84-90
  • Chahoud G; Aude YW; Mehta JL, Dietary recommendations in the prevention and treatment of coronary heart disease: do we have the ideal diet yet? Am J Cardiol – 15-NOV-2004; 94(10): 1260-7
  • Bunea R, El Farrah K, Deutsch L. Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia. Altern Med Rev 2004;9:420-8.
  • Studer M, Briel M, Leimenstoll B, et al. Effect of different antilipidemic agents and diets on mortality: a systematic review. Arch Intern Med 2005;165:725-30.
  • Yzebe D, Lievre M. Fish oils in the care of coronary heart disease patients: a meta-analysis of randomized controlled trials. Fundam Clin Pharmacol 2004;18:581-92.
  • Kidd PM ,Integrated brain restoration after ischemic stroke–medical management, risk factors, nutrients, and other interventions for managing inflammation and enhancing brain plasticity. Altern Med Rev – 01- MAR-2009; 14(1): 14-35.
  • Kidd PM, Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern Med Rev – 01-SEP-2007; 12(3): 207-27